Participants can hear from experts as they discuss the impact of next generation sequencing, the utility of a molecular tumour board and phase I clinic in advancing cancer patients' care. The webinar will also highlight ongoing research and share real-world experience of integrating molecular profiling in an Asian tertiary cancer unit.